Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study

被引:47
作者
Gerstein, H. C. [1 ,2 ]
Islam, S. [1 ,2 ]
Anand, S. [1 ,2 ]
Almahmeed, W. [3 ]
Damasceno, A. [4 ]
Dans, A. [5 ]
Lang, C. C. [6 ]
Luna, M. A. [7 ]
McQueen, M. [2 ,8 ]
Rangarajan, S. [1 ,2 ]
Rosengren, A. [9 ]
Wang, X. [10 ]
Yusuf, S. [1 ,2 ]
机构
[1] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada
[2] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada
[3] Sheikh Khalifa Med City, Div Cardiol, Abu Dhabi, U Arab Emirates
[4] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique
[5] Univ Philippines, Dept Med, Coll Med, Manila, Philippines
[6] Univ Dundee, Div Med Sci, Dundee, Scotland
[7] Univ Virginia, Dept Med, Charlottesville, VA USA
[8] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada
[9] Sahlgrens Acad, Inst Med, Gothenburg, Sweden
[10] Beijing Hypertens League Inst, Lab Human Genet, Beijing, Peoples R China
基金
加拿大健康研究院;
关键词
Case-control; Diabetes; Dysglycaemia; Glycated haemoglobin; Myocardial infarction; ABNORMAL GLUCOSE REGULATION; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; 52; COUNTRIES; DIABETES-MELLITUS; HEMOGLOBIN A(1C); HEART-FAILURE; BLOOD-GLUCOSE; MORTALITY; HOSPITALIZATION;
D O I
10.1007/s00125-010-1871-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis Although diabetes is an established risk factor for myocardial infarction (MI), disease control may vary. HbA(1c) is a reliable index of ambient glucose levels and may provide more information on MI risk than diabetes status. Methods The relationship between HbA(1c) levels in MI patients and controls who participated in the 52 country INTERHEART study was analysed. Results In 15,780 participants with a HbA(1c) value (1,993 of whom had diabetes), the mean (SD) levels for HbA(1c) were 6.15% (1.10) in the 6,761 MI patients and 5.85% (0.80) in the control participants. After adjustment for age, sex and nine major MI risk factors (including diabetes), higher HbA(1c) fifths above the lowest fifth (HbA(1c) <5.4%) were associated with progressively higher OR of MI, with OR for the highest HbA(1c) fifth (>= 6.12%) being 1.55 (95% CI 1.37-1.75). When analysed as a continuous variable after adjustment for the same factors, every 1% higher HbA(1c) value was associated with 19% (95% CI 14-23) higher odds of MI, while every 0.5% higher HbA(1c) was associated with 9% higher odds of MI (95% CI 7-11). Concordant relationships were noted across subgroups, with a higher OR noted in younger people, patients without diabetes or hypertension, and those from some regions and ethnicities. Conclusions/interpretation The HbA(1c) value provides more information on MI odds than self-reported diabetes status or many other established risk factors. Every 1% increment independently predicts a 19% higher odds of MI after accounting for other MI risk factors including diabetes.
引用
收藏
页码:2509 / 2517
页数:9
相关论文
共 24 条
  • [1] The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe -: The Euro Heart Survey on diabetes and the heart
    Bartnik, M
    Rydén, L
    Ferrari, R
    Malmberg, K
    Pyörälä, K
    Simoons, M
    Standl, E
    Soler-Soler, J
    Öhrvik, J
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (21) : 1880 - 1890
  • [2] Brunner EJ, 2006, DIABETES CARE, V29, P26
  • [3] Prevention of diabetes and cardiovascular' disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial
    Califf, Robert M.
    Boolell, Mitradev
    Haffner, Steven M.
    Bethel, M. Angelyn
    McMurray, John
    Duggal, Anil
    Holman, Rury R.
    [J]. AMERICAN HEART JOURNAL, 2008, 156 (04) : 623 - 632
  • [4] *CDCP, PREV DIAGN DIAB AG U
  • [5] Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)
    Gerstein, Hertzei C.
    [J]. AMERICAN HEART JOURNAL, 2008, 155 (01) : 26 - 32
  • [6] The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure -: An analysis of the Candesartan in Heart failure:: Assessment of Reduction in Mortality and Morbidity (CHARM) program
    Gerstein, Hertzel C.
    Swedberg, Karl
    Carlsson, Jonas
    McMurray, John J. V.
    Michelson, Eric L.
    Olofsson, Bertil
    Pfeffer, Marc A.
    Yusuf, Salim
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (15) : 1699 - 1704
  • [7] Is it possible to reduce cardiovascular risk with glucose-lowering approaches?
    Gerstein, Hertzel C.
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2009, 5 (05) : 270 - 275
  • [8] Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk
    Held, C.
    Gerstein, H. C.
    Yusuf, S.
    Zhao, F.
    Hilbrich, L.
    Anderson, C.
    Sleight, P.
    Teo, K.
    [J]. CIRCULATION, 2007, 115 (11) : 1371 - 1375
  • [9] The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey
    Hu, Da-Yi
    Pan, Chang-Yu
    Yu, Jin-Ming
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (21) : 2573 - 2579
  • [10] *INT DIAB FED, 2008, PREV EST DIAB 2007